| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,378,000 | 3,475,000 | 4,345,000 | 4,146,000 | | Cost of Revenue | 2,495,000 | 2,801,000 | 3,387,000 | 3,117,000 | | | Gross Profit | 883,000 | 674,000 | 958,000 | 1,029,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 95,000 | 84,000 | 79,000 | 109,000 | | Non Recurring | (13,000) | (94,000) | 187,000 | (136,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 801,000 | 684,000 | 692,000 | 1,056,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 259,000 | (66,000) | 296,000 | 870,000 | | Earnings Before Interest And Taxes | 1,060,000 | 618,000 | 988,000 | 1,926,000 | | Interest Expense | 391,000 | 482,000 | 458,000 | 469,000 | | Income Before Tax | 669,000 | 136,000 | 530,000 | 1,457,000 | | Income Tax Expense | 175,000 | 49,000 | 168,000 | 317,000 | | Minority Interest |
-
| (148,000) | (213,000) | (257,000) | | | | Net Income From Continuing Ops | 501,000 | (66,000) | 145,000 | 903,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 19,000 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 501,000 | (47,000) | 145,000 | 903,000 | | Preferred Stock And Other Adjustments | (283,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $218,000 | ($47,000) | $145,000 | $903,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
